Llwytho...
Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis
Purpose: Ranolazine is a novel anti-angina treatment approved in the United States for chronic stable angina. Ranolazine pharmacokinetics have not been studied previously in patients who receive maintenance hemodialysis. This study describes the pharmacokinetics of ranolazine and three major metabol...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ren Fail |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6442103/ https://ncbi.nlm.nih.gov/pubmed/30909832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2019.1585371 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|